External carotid effects of 2-(2-aminoethyl)-quinoline (D-1997) in vagosympathectomized dogs

European Journal of Pharmacology

Volumn 356, Issue 1, 1998, Pages 15-23

  Villalón, Carlos M ^a   López Muñoz, Francisco J ^a   Perusquía, Mercedes ^b   Terrón, José A ^a  

^a Secc de Terap Experimental   (Mexico)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 HT(1B 1D) receptors; Carotid blood flow; D 1997; Sumatriptan; Vasoconstriction

Indexed keywords

2 (2 AMINOETHYL)QUINOLINE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN AGONIST; SUMATRIPTAN SUCCINATE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY FLOW; CONTROLLED STUDY; DOG; DRUG EFFECT; EXTERNAL CAROTID ARTERY; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; VAGUS NERVE; VASOCONSTRICTION;

ANIMALS; CAROTID ARTERY, EXTERNAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMIC PROCESSES; MALE; METHIOTHEPIN; QUINOLINES; REGIONAL BLOOD FLOW; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SODIUM CHLORIDE; SUMATRIPTAN; SYMPATHECTOMY; VAGOTOMY; VASOCONSTRICTION;

EID: 0032575583     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00493-2     Document Type: Article

References (32)

1. Bom A.H., Duncker D.J., Saxena P.R., Verdouw P.D. 5-HT-induced tachycardia in the pig: possible involvement of a new type of 5-HT receptor. Br. J. Pharmacol. 93:1988;663-671.
2. 1-like receptor agonist. Br. J. Pharmacol. 96:1989;379-387.
3. 1-like receptors. Br. J. Pharmacol. 104:1991;183-189.
4. Feniuk W., Hare J., Humphrey P.P.A. Analysis of the mechanism of 5-hydroxytryptamine-induced vasopressor responses in ganglion-blocked anaesthetized dogs. J. Pharm. Pharmacol. 33:1981;155-160.
5. Feniuk W., Humphrey P.P.A., Perren M.J. The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br. J. Pharmacol. 96:1989;83-90.
6. Filep J.G., Herman F., Battistini B., Chabrier P.E., Braquet P., Sirois P. Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin. J. Cardiovasc. Pharmacol. 17:1991;S216-S218. (Suppl. 7).
7. Fozard J.R., Mobarok A.T.M., Newgrosh G. Blockade of serotonin receptors on autonomic nerves by (-)-cocaine and some related compounds. Eur. J. Pharmacol. 59:1979;195-210.
8. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
9. Humphrey P.P.A., Feniuk W., Watts W. Prejunctional effects of 5-hydroxytryptamine on noradrenergic nerves in the cardiovascular system. Fed. Proc. 42:1983;218-222.
10. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol. 94:1988;1123-1132.
11. Lemberger L., Rowe H., Carmichael R., Crabtree R., Horng J.S., Bymaster F., Wong D. Fluoxetine, a selective serotonin uptake inhibitor. Clin. Pharmacol. Ther. 23:1978;421-429.
12. 1D subtype. Br. J. Pharmacol. 102:1991;191-197.
13. Rosenblum W.I., Nelson G.H. Endothelium-dependent constriction demonstrated in vivo in mouse cerebral arterioles. Circ. Res. 63:1988;837-843.
14. Saxena P.R., Villalón C.M. Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol. 15:1990;S17-S34. (Suppl. 7).
15. 1-like receptors: a time to bid good-bye. Trends Pharmacol. Sci., in press.
16. Seager J.M., Clark A.H., Garland C.J. Endothelium-dependent contractile responses to 5-hydroxytryptamine in the rabbit basilar artery. Br. J. Pharmacol. 105:1992;424-428.
17. 1D receptor antagonist. Behav. Brain Res. 73:1996;157-161.
18. Steel, R.G.D., Torrie, J.H., 1980. Principles and Procedures of Statistics, A Biomedical Approach, 2nd edn. McGraw-Hill Kogakusha, Tokyo.
19. Takahashi T., Hisa H., Satoh S. Serotonin-induced renin release in the dog kidney. Eur. J. Pharmacol. 193:1991;315-320.
20. Tallarida, R.J., Murray, R.B., 1981. Manual of Pharmacologic Calculations with Computer Programs. Springer Verlag, New York.
21. 7 receptor: a target for novel therapeutic avenues? I. Drugs (in press).
22. 1-like receptors in the canine basilar artery. Arch. Int. Pharmacodyn. Ther. 237:1994;56-68.
23. Terrón, J.A., Hong, E., Villalón, C.M., 1994b. Possible involvement of a novel 5-HT receptor type in the canine external carotid vasoconstriction induced by 2-(2-aminoethyl) quinoline (D-1997). Proceedings of the XIIth International Congress of Pharmacology (IUPHAR), Montreal, July 24-29, 1994. Abstract No. P1.13.99.
24. 1D subtype. Br. J. Pharmacol. 113:1994;13-20.
25. 1-like receptors in the increase in external carotid blood flow induced by 5-hydroxytryptamine in the dog. Eur. J. Pharmacol. 240:1993;9-20.
26. 1-like receptors mediating the increase in external carotid blood flow in the dog. Drug Develop. Res. 29:1993;271-281.
27. Villalón C.M., Ramírez-San Juan E., Castillo C., Castillo E., López-Muñoz F.J., Terrón J.A. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs. Br. J. Pharmacol. 116:1995;2778-2784.
28. 1-like receptors mediating external carotid vasoconstriction in vagosympathectomized dogs. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;550-556.
29. 7 receptor. Br. J. Pharmacol. 120:1997;1319-1327.
30. Villalón C.M., De Vries P., Saxena P.R. Serotonin receptors as cardiovascular targets. Drug Disc. Today. 2:1997;294-300.
31. Wong D.T., Bymaster F.P., Horng J.S., Molloy B.B. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. J. Pharmacol. Exp. Ther. 193:1975;804-811.
32. Zaimis E. Pharmacology of the autonomic nervous system. Ann. Rev. Pharmacol. 4:1964;365-400.